New Clinical Trial at UTHealth Houston Tests Gene Therapy Vector That Delivers Drug Aimed at Stopping Overactive Bladder in Patients with Spinal Cord Injury
University of Texas Health Science Center at HoustonA modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.